X0708
D
LIVE
0001544227
Tempest Therapeutics, Inc.
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE
CA
CALIFORNIA
94005
415-798-8589
DELAWARE
None
Millendo Therapeutics, Inc.
OvaScience, Inc.
Corporation
true
Matthew
Angel
Tempest Therapeutics, Inc.
2000 Sierra Point Parkway, Suite 400
Brisbane
CA
CALIFORNIA
94005
Executive Officer
Director
President and Chief Executive Officer
Justin
Trojanowski
Tempest Therapeutics, Inc.
2000 Sierra Point Parkway, Suite 400
Brisbane
CA
CALIFORNIA
94005
Executive Officer
Vice President, Finance, Principal Financial Officer and Corporate Secretary
John
David
Yee
Tempest Therapeutics, Inc.
2000 Sierra Point Parkway, Suite 400
Brisbane
CA
CALIFORNIA
94005
Director
William
Drake
Richey
Tempest Therapeutics, Inc.
2000 Sierra Point Parkway, Suite 400
Brisbane
CA
CALIFORNIA
94005
Director
Biotechnology
Decline to Disclose
- 06b
false
2026-05-29
true
true
true
true
true
Common Stock Purchase Warrant, including underlying shares of common stock
true
0
4056552
4056552
0
Offering amount for common stock purchase warrant does not include proceeds of $2028276 for warrant exercise. (amounts rounded)
false
1
0
0
0
false
Tempest Therapeutics, Inc.
/s/ Matthew Angel
Matthew Angel
President and Chief Executive Officer
2026-06-22